Stay updated on Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.

Latest updates to the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision history shows a minor update: v3.4.2 was added and v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry (v3.4.1) was added and the v3.4.0 entry was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedA glossary toggle was added, the changes display now uses color-coding (green for additions, red for deletions), and a new revision label (v3.4.0) appears.SummaryDifference0.7%

- Check58 days agoChange DetectedNew revision entry v3.3.4 was added to the history and v3.3.3 was removed. This is an administrative update to the record history and does not alter trial data or status.SummaryDifference0.1%

- Check79 days agoChange DetectedThe history list now includes a new entry: Revision: v3.3.3. The HHS Vulnerability Disclosure footer link was removed.SummaryDifference0.1%

Stay in the know with updates to Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.